News Focus
News Focus
icon url

FeMike

06/19/25 1:01 PM

#772199 RE: QL300 #772198

I mean, it’s just a value proposition determination.

I am by no means certain this is what is happening. And in the case it is approved, which I still give a more than credible probability to, the value is enough to outweigh the risk of non approval in my opinion.

That’s how any prerev biotech investment works. Nobody is certain of outcomes either way.
icon url

exwannabe

06/19/25 1:42 PM

#772202 RE: QL300 #772198

If you truly believe that, you would sell now and move on. This company probably won't survive without approval.


So, by that logic you think that on approval the stock only goes to $0.60 or so?

Even I would expect better if MHRA gives the thumbs up.

https://media.gifdb.com/dodgeball-chuck-norris-thumbs-up-gw1y5db5hvvz92hg.gif